Cargando…
Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
PURPOSE: Anaplastic thyroid cancer is known to have a poor prognosis due to its aggressive and rapid metastasis with median survival of less than 6 months. Multimodal treatment involving surgery and chemoradiotherapy has been used to improve the survival of patients. Here, we retrospectively review...
Autores principales: | Lim, Sun Min, Shin, Sang-Joon, Chung, Woong Youn, Park, Cheong Soo, Nam, Kee-Hyun, Kang, Sang-Wook, Keum, Ki Chang, Kim, Joo Hang, Cho, Jae Yong, Hong, Yun Kyoung, Cho, Byoung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282954/ https://www.ncbi.nlm.nih.gov/pubmed/22318823 http://dx.doi.org/10.3349/ymj.2012.53.2.352 |
Ejemplares similares
-
Anaplastic Thyroid Carcinoma: A Therapeutic Dilemma
por: Chang, Hang-Seok, et al.
Publicado: (2005) -
Postoperative Complications of Thyroid Cancer in a Single Center Experience
por: Lee, Yong Sang, et al.
Publicado: (2010) -
Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
por: Kim, Soo Young, et al.
Publicado: (2020) -
Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome
por: Jeong, Jun Soo, et al.
Publicado: (2012) -
Coexistence of parathyroid adenoma and papillary thyroid carcinoma
por: Lee, Yong Sang, et al.
Publicado: (2011)